Loomis Sayles & CO L P Halozyme Therapeutics, Inc. Transaction History

Loomis Sayles & CO L P

$76.2 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$32.86 - $55.7 $283,680 - $480,858	8,633 Added 0.41%	2,129,204 $81.3 Million
Q4 2022 Feb 10, 2023	SELL	$40.06 - $59.44 $1.11 Million - $1.65 Million	-27,702 Reduced 1.29%	2,120,571 $121 Million
Q3 2022 Nov 14, 2022	SELL	$38.53 - $51.78 $932,618 - $1.25 Million	-24,205 Reduced 1.11%	2,148,273 $84.9 Million
Q2 2022 Aug 05, 2022	SELL	$37.35 - $48.3 $477,930 - $618,046	-12,796 Reduced 0.59%	2,172,478 $95.6 Million
Q1 2022 May 13, 2022	BUY	$31.97 - $41.06 $8.23 Million - $10.6 Million	257,536 Added 13.36%	2,185,274 $87.1 Million
Q4 2021 Feb 14, 2022	SELL	$31.82 - $40.75 $1.35 Million - $1.72 Million	-42,317 Reduced 2.15%	1,927,738 $77.5 Million
Q3 2021 Nov 12, 2021	SELL	$38.47 - $46.42 $197,697 - $238,552	-5,139 Reduced 0.26%	1,970,055 $80.1 Million
Q2 2021 Aug 13, 2021	SELL	$38.84 - $51.31 $235,448 - $311,041	-6,062 Reduced 0.31%	1,975,194 $89.7 Million
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $148,952 - $193,966	-3,770 Reduced 0.19%	1,981,256 $82.6 Million
Q4 2020 Feb 12, 2021	BUY	$25.81 - $43.62 $13.9 Million - $23.5 Million	538,171 Added 37.2%	1,985,026 $84.8 Million
Q3 2020 Nov 12, 2020	BUY	$25.74 - $29.63 $708,339 - $815,387	27,519 Added 1.94%	1,446,855 $38 Million
Q2 2020 Aug 14, 2020	BUY	$16.25 - $26.81 $2 Million - $3.31 Million	123,333 Added 9.52%	1,419,336 $38.1 Million
Q1 2020 May 15, 2020	BUY	$13.9 - $21.83 $112,006 - $175,906	8,058 Added 0.63%	1,296,003 $23.3 Million
Q4 2019 Feb 14, 2020	SELL	$14.93 - $19.53 $62,974 - $82,377	-4,218 Reduced 0.33%	1,287,945 $22.8 Million
Q3 2019 Nov 13, 2019	BUY	$15.2 - $17.69 $19.6 Million - $22.9 Million	1,292,163 New	1,292,163 $20 Million

Others Institutions Holding HALO

# of Institutions

542

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$930 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$681 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$350 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$215 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$180 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Account